The Nanosynth team traveled to New Delhi on September 15 to present updated results of the on-going Phase I project to the Grand Challenges in TB Control Committee including updated sensitivity and specificity results that are approaching WHO targets for a new TB screening/triage test. The team also presented a Phase II proposal to further test and validate the TB screening technology developed during Phase I.